Theranos Inc - Product Pipeline Analysis, 2017 Update

GlobalData
33 Pages - GLDATA62887
$750.00

Summary

Theranos Inc (Theranos),formerly RealTime Cures, Inc., is a healthcare technology company. It develops all the medical devices including hardware and consumables. The company’s product portfolio includes miniLab devices and Sample Collection Devices (SCD). Theranos’s miniLab is a portable device which is designed to process and analyze very small samples of blood. Its SCD is designed to collect small blood samples from a finger prick into a pair of Nanotainer tubes. The company developed a remote server, Theranos Virtual Analyzer which is developed to communicate with the Theranos miniLab through secure wired or wireless connections. Theranos is headquartered in Palo Alto, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theranos Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Theranos Inc Company Overview 4
Theranos Inc Company Snapshot 4
Theranos Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Theranos Inc – Pipeline Analysis Overview 7
Theranos Inc - Key Facts 7
Theranos Inc - Major Products and Services 8
Theranos Inc Pipeline Products by Development Stage 9
Theranos Inc Pipeline Products Overview 11
Ebola Blood Test 11
Ebola Blood Test Product Overview 11
HSV-1 IgG Test - Venous/Capillary 12
HSV-1 IgG Test - Venous/Capillary Product Overview 12
miniLab System 13
miniLab System Product Overview 13
Nanotainer Tubes 14
Nanotainer Tubes Product Overview 14
Sample Collection Device 15
Sample Collection Device Product Overview 15
Theranos HSV-1 IgG Assay - CLIA Waived 16
Product Status 16
Theranos Virtual Analyzer 17
Theranos Virtual Analyzer Product Overview 17
Zika Nucleic Acid-Amplification-Based Assay 18
Zika Nucleic Acid-Amplification-Based Assay Product Overview 18
Theranos Inc - Key Competitors 19
Theranos Inc - Key Employees 20
Theranos Inc - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Theranos Inc, Recent Developments 22
Jan 17, 2017: Theranos Announces Engineering Experts Join Company’s New Technology Advisory Board 22
Jan 06, 2017: Theranos Announces Company Re-engineers Operations 23
Dec 12, 2016: Theranos Enhances Executive Ranks 23
Dec 01, 2016: Theranos appoints new board member 24
Oct 05, 2016: An Open Letter From Elizabeth Holmes 24
Aug 25, 2016: Theranos to appeal CMS sanctions 25
Aug 01, 2016: Theranos unveils its diagnostic-testing technologies at American Association for Clinical Chemistry meeting 25
Jul 21, 2016: Theranos names new executives: vice president, regulatory and quality, and chief compliance officer 26
Jul 07, 2016: Theranos Receives Notice of Sanctions from the Centers for Medicare & Medicaid Services 27
May 11, 2016: Theranos Announces Expansion of Board of Directors and New Organizational Structure 28
Appendix 30
Methodology 30
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Theranos Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Theranos Inc Pipeline Products by Equipment Type 5
Theranos Inc Pipeline Products by Indication 6
Theranos Inc, Key Facts 7
Theranos Inc, Major Products and Services 8
Theranos Inc Number of Pipeline Products by Development Stage 9
Theranos Inc Pipeline Products Summary by Development Stage 10
Ebola Blood Test - Product Status 11
Ebola Blood Test - Product Description 11
HSV-1 IgG Test - Venous/Capillary - Product Status 12
HSV-1 IgG Test - Venous/Capillary - Product Description 12
miniLab System - Product Status 13
miniLab System - Product Description 13
Nanotainer Tubes - Product Status 14
Nanotainer Tubes - Product Description 14
Sample Collection Device - Product Status 15
Sample Collection Device - Product Description 15
Product Status 16
Theranos HSV-1 IgG Assay - CLIA Waived - Product Description 16
Theranos Virtual Analyzer - Product Status 17
Theranos Virtual Analyzer - Product Description 17
Zika Nucleic Acid-Amplification-Based Assay - Product Status 18
Zika Nucleic Acid-Amplification-Based Assay - Product Description 18
Theranos Inc, Key Employees 20
Glossary 31

List of Figures
Theranos Inc Pipeline Products by Equipment Type 5
Theranos Inc Pipeline Products by Development Stage 9

$750.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838